FABP4 Inhibitor
Catalog No. A13404
FABP4 Inhibitor是一种细胞可渗透的联苯唑氧乙酸酯,通过靶向其脂肪酸结合口袋(在使用1,8-氨基水杨酸的竞争性结合试验中Ki = < 2 nM),作为脂肪细胞脂肪酸结合蛋白(aFABP/aP2)的有效和选择性抑制剂,同时对肌肉和表皮FABP氏病表现出低得多的亲和力(Ki分别为250 nM和350 nM)。
Catalog Num | A13404 |
---|---|
M. Wt | 474.55 |
Formula | C31H26N2O3 |
Purity | >98% |
Storage | at -20°C 3 years Powder |
CAS No. | 300657-03-8 |
Synonyms | |
SMILES | CCC1=C(C(=NN1C2=CC=CC=C2C3=CC(=CC=C3)OCC(=O)O)C4=CC=CC=C4)C5=CC=CC=C5 |
FABP4 Inhibitor是一种细胞可渗透的联苯唑氧乙酸酯,通过靶向其脂肪酸结合口袋(在使用1,8-氨基水杨酸的竞争性结合试验中Ki = < 2 nM),作为脂肪细胞脂肪酸结合蛋白(aFABP/aP2)的有效和选择性抑制剂,同时对肌肉和表皮FABP氏病表现出低得多的亲和力(Ki分别为250 nM和350 nM)。
In vitro | DMSO | 89 mg/mL (187.54 mM) | |
Water | Insoluble | ||
Ethanol | 17 mg/mL (35.82 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.07 mL | 105.36 mL | 210.73 mL |
0.5 mM | 4.21 mL | 21.07 mL | 42.15 mL |
1 mM | 2.11 mL | 10.54 mL | 21.07 mL |
5 mM | 0.42 mL | 2.11 mL | 4.21 mL |
*The above data is based on the productmolecular weight 474.55. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.